Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Pharmaceutical Manufacturing and Supply

Active

Federal

Response Deadline08/05/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the manufacture and supply of Erythromycin Ophthalmic Ointment, USP, adhering to all applicable FDA regulations, current good manufacturing practices, and specific labeling requirements set forth by the Defense Logistics Agency. The product must be assigned the National Drug Code NDC 00574-4024-39 and meet stringent quality and compliance standards to ensure safety and efficacy for military and federal healthcare use. Production and delivery are to be executed in compliance with cGMP guidelines and DLA labeling protocols, ensuring traceability and regulatory alignment throughout the supply chain. This subcontract, categorized under NAICS code 325412 for pharmaceutical and medicine manufacturing, is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as Fort Lewis, WA, with a zip code of 98433-9500. The solicitation was posted on July 30, 2026, and responses are due by August 5, 2026, indicating a narrow five-day window for submission. Interested parties must submit proposals through the official DIBBS portal linked in the contract details, as no point of contact information is provided and all communications will be handled through the designated procurement system.

General Info

Manufacture and supply of Erythromycin Ophthalmic Ointment NDC 00574-4024-39 per FDA, cGMP, and DLA requirements for military use.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT LEWIS, WA, 98433-9500, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 30

subcontract

Response DeadlineAug 5

Submission deadline

Response Deadline

08/05/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and supply of Erythromycin Ophthalmic Ointment, USP, compliant with FDA, cGMP, NDC 00574-4024-39, and DLA labeling standards.

Similar Contracts

Same NAICS industry code

Flu Vaccine Supply (Flucelvax Trivalent)The contract entails the supply of 2,000 units of FDA-approved Flucelvax Trivalent vaccine in 0.5 ml pre-filled single-dose syringes without needles, specifically for vaccination of the National Geospatial-Intelligence Agency workforce. The vaccine is intended for seasonal influenza prevention and must meet all regulatory standards for safety and efficacy as defined by the FDA. Delivery is required to be performed at the designated place of performance in Springfield, with all units shipped in compliant, ready-to-administer packaging. The contract is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The solicitation was posted on July 31, 2026, and responses are due by August 10, 2026, at 10:00 PM Eastern Time. The contracting entity is the Department of Defense through the National Geospatial-Intelligence Agency, and no set-aside provisions are indicated, meaning the opportunity is open to all qualified vendors regardless of business size or ownership status.

National Geospatial-Intelligence Agency

POSTED

DEADLINE

Flu Vaccines and Associated Supplies

Solicitation # HM047626Q0030

The solicitation for Flu Vaccines and Associated Supplies under HM047626Q0030 has been amended to remove the clause 52.219-6 NOTICE OF TOTAL SMALL BUSINESS SET-ASIDE, indicating the procurement is no longer restricted to small businesses. The government has also provided responses to questions received from potential offerors, with the full Q&A attached for reference. The deadline for submitting proposals has been extended to 5:00 p.m. Central Time on August 10, 2026, and all proposal submission requirements have been updated accordingly to reflect this new date. All other terms and conditions of the original solicitation remain in effect. The award will be made to the responsible offeror submitting the lowest price technically acceptable quote, as determined by the LPTA evaluation method. Offerors must review the full solicitation document and Statement of Work, and submit a completed quote sheet as required. The contracting activity is managed by the National Geospatial-Intelligence Agency under the Department of Defense, with the primary point of contact being Kathleen Dee at the provided email and phone number. The place of performance is in Springfield, Virginia, while the issuing office is located in Arnold, Missouri.

National Geospatial-Intelligence Agency

POSTED

DEADLINE

Cannabis Product Infusion and FormulationThe contract titled Cannabis Product Infusion and Formulation is a subcontract under the City of Los Angeles, targeting the precise infusion of cannabis extracts into consumer products such as edibles, tinctures, and topicals, with strict adherence to dosing accuracy and regulatory compliance. The work is performance-based and must meet industry standards for quality, consistency, and safety within the regulated cannabis market. The place of performance is designated as Los Angeles, California, with a zip code of 90021, indicating that all operations, including formulation, testing, and packaging, must occur within this localized jurisdiction to align with municipal and state cannabis regulations. The NAICS code 325412 classifies the contract under Pharmaceutical and Medicine Manufacturing, emphasizing the technical and scientific rigor required for product development. The solicitation was posted on July 31, 2026, and while it does not specify a set-aside type or organizational preference, the focus on precision infusion implies a need for specialized expertise in extraction chemistry, dosage control, and Good Manufacturing Practices. The absence of a point of contact or detailed solicitation number suggests this may be an open or pre-qualified subcontract opportunity, with all activity tied to compliance with California’s legal cannabis framework and Los Angeles municipal ordinances.

City of Los Angeles

POSTED

DEADLINE

Supply of Vitamin and Mineral Fortified BlendsThe contract pertains to the production and supply of micronutrient-fortified nutritional blends designed to combat vitamin and mineral deficiencies within clinical environments. These products are intended for use in healthcare settings to support patient recovery and nutritional adequacy, particularly in populations at risk of deficiencies. The work is classified under NAICS code 325412, indicating manufacturing of pharmaceutical and botanical products, and is structured as a subcontract, suggesting it is part of a larger procurement effort led by the South East Regional Health Authority under the Government of Jamaica. The solicitation was posted on July 30, 2026, and performance is expected to occur within Jamaica, though specific location details are not provided. The contract does not specify a set-aside designation or point of contact, indicating that further details may be obtained through the provided government portal link.

South East Regional Health Authority

POSTED

DEADLINE

Pharmaceutical Supply – Bupivacaine and Epinephrine InjectionThe contract is for the supply of two cartons of Bupivacaine and Epinephrine Injection, each containing 50 cartridges of 1.8 mL, with a concentration of 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL, adhering to strict FDA and military medical marking requirements. The药品 must meet all applicable regulatory and military standards to ensure compatibility and safety within defense medical operations. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required in San Diego, CA, 92136. The opportunity was posted on July 30, 2026, and responses must be submitted by August 5, 2026, with all bids expected to comply with the specified product configuration, packaging, and labeling protocols mandated for military use.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Ultrasound Transmission Gel Manufacturing and FormulationThe contract seeks a manufacturer to produce a medical-grade ultrasound transmission gel that is tinted and viscous, formulated as an aqueous solution meeting stringent specifications for pH, viscosity, and a minimum shelf life of 60 months. The gel must be safe for direct skin contact and compatible with ultrasound transducers, ensuring optimal acoustic coupling while maintaining integrity over extended storage periods. All production processes and final product quality must adhere to medical-grade standards, with rigorous controls to guarantee consistency, sterility, and absence of harmful contaminants. Performance of this subcontract is tied to Fort Bragg, North Carolina, with a response deadline of August 6, 2026, following a posting date of July 30, 2026, under the NAICS code 325412 for pharmaceutical and botanical manufacturing. The contracting entity operates under the Department of Defense, specifically within the Medical Supply Chain FSH, indicating this is a defense-related procurement likely intended for military medical facilities. No set-aside information is provided, and submissions must align precisely with technical requirements for composition, labeling, packaging, and documentation to be considered for award.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Manufacturing – Tolnaftate Powder (USP 1%)The contract calls for the manufacture of Tolnaftate Powder, USP 1%, in 45-gram units, adhering strictly to United States Pharmacopeia standards, Good Manufacturing Practices, and applicable military specifications. Production must include comprehensive batch testing and rigorous quality control measures to ensure consistency, purity, and potency throughout the manufacturing process. All units must meet exacting pharmaceutical and defense-grade requirements, with full traceability and documentation to support regulatory compliance and operational readiness. The solicitation is classified as a subcontract under NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as FPO with ZIP code 09570, indicating delivery to a military postal address. The response deadline is August 5, 2026, with the solicitation posted on July 30, 2026, leaving a limited window for qualified manufacturers to submit proposals. While no specific set-aside status or point of contact is provided, interested parties must reference the official DIBBS portal link to access full solicitation details and ensure compliance with all submission requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dental Bonding Agent SupplyThe contract involves the supply and delivery of a commercial off-the-shelf dental bonding agent known as the Ultra-Etch 4PK Kit, which includes viscous 35% phosphoric acid gel, syringes, and micro tips, all packaged and labeled to meet federal and military compliance standards. The product must be shipped in accordance with strict regulatory requirements to ensure safety, efficacy, and readiness for use in military medical environments. The solicitation is issued under the NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through the Medical Supply Chain FSH. The place of performance is specified as Suffolk, Virginia, with a zip code of 23435-5000, indicating where the delivered goods will be received and utilized. The solicitation was posted on July 30, 2026, with a response deadline of August 6, 2026, giving potential suppliers just one week to submit their proposals. This is structured as a subcontract opportunity, meaning it is likely part of a larger procurement effort, and no specific set-aside classification has been designated, indicating it is open to all eligible contractors regardless of business size or category. The contract is accessible via the DIBBS platform, which is the Department of Defense’s official system for managing procurement actions, and all submissions must comply with the technical, logistical, and regulatory demands outlined to ensure seamless integration into military dental care protocols.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Dental Calcium Hydroxide Paste Manufacturing & SupplyThe contract calls for the manufacture and supply of a radiopaque, antibacterial calcium hydroxide paste specifically designed for dental endodontic applications, with strict adherence to FDA and DLA specifications. The scope encompasses the full lifecycle of the product including formulation development, packaging, labeling, and compliance with safety data sheet requirements to ensure regulatory and clinical suitability. The product must meet precise technical standards to function effectively in root canal treatments, combining radiopacity for accurate imaging with antibacterial properties to inhibit microbial growth. Performance is designated to occur in Suffolk, Virginia, with a response deadline of August 6, 2026, and the solicitation is classified as a subcontract under NAICS code 325412 for pharmaceutical and cosmetic manufacturing. The contracting organization is the Department of Defense through its Medical Supply Chain FSH unit, indicating this is a defense-related procurement aimed at equipping military dental services. All materials and processes must align with federal procurement and quality control mandates, and submission is managed through the DLA’s DIBBS platform.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Supplier – BenzoCaine and Menthol LozengesThe contract calls for the supply of six units of CHLORASEPTIC MAX lozenges, each containing 15 mg of benzocaine and 10 mg of menthol, to meet stringent FDA, OSHA, and Department of Defense packaging and labeling requirements. The deliverables must comply with all regulatory standards for pharmaceutical products intended for military and federal use, ensuring safe handling, accurate identification, and proper storage conditions. The solicitation is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a limited window for potential suppliers to prepare and submit proposals. The place of performance is designated as Ellsworth Air Force Base, South Dakota, with a zip code of 57706-4821, indicating the final destination for the lozenges. Although the solicitation number and point of contact details are not provided in the data, the official record is accessible through the DIBBS platform at the specified URL. All parties must adhere to DoD procurement protocols, including documentation, quality assurance, and delivery timelines to meet operational readiness needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Dextrose Injection 5% (NSN 6505013306252)The contract requires the supply and delivery of Dextrose Injection 5%, USP, 1000 mL, in 12-unit cases, in full compliance with U.S. Pharmacopeial standards and the Defense Logistics Agency’s technical specifications. The product, identified by NSN 6505013306252, is intended for federal medical use and must meet stringent quality, packaging, and labeling requirements to ensure safety and efficacy. Performance is to be executed at the FPO mail facility with ZIP code 96669, reflecting the logistical nature of military medical supply distribution. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract opportunity managed by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Responses are due by August 5, 2026, with the solicitation posted on July 30, 2026, providing a seven-day window for interested vendors to submit proposals through the DIBBS platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sterile Pharmaceutical Manufacturing (WATER FOR INJECTION, USP)The contract pertains to the manufacture and packaging of sterile water for injection in 1000mL plastic bags, strictly adhering to USP, FDA, and DLA standards to ensure pharmaceutical quality and safety. The product must be produced under controlled sterile conditions and meet all regulatory requirements for parenteral use, with packaging in compliant plastic bags that maintain sterility and integrity throughout distribution and use. The work is designated as a subcontract under NAICS code 325412, specifically for pharmaceutical manufacturing, and is tied to the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026, indicating a tight turnaround for qualified manufacturers to submit proposals. Performance of the contract is required at Fort Bragg, North Carolina, with a zip code of 28310, suggesting direct logistical coordination with military medical supply operations. The contract does not specify a set-aside type, meaning it is open to all eligible subcontractors regardless of business size or ownership status. All submissions must align with the defense supply chain’s stringent quality and compliance protocols to support critical medical needs within the DoD healthcare system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

OMEPRAZOLE EXTENDED-RE

Solicitation # SPE2DP-26-T-4251

OMEPRAZOLE EXTENDED-RELEASE CAPSULES, 20 MG DELAYED RELEASE, in 90-count bottles, are being procured under solicitation SPE2DP-26-T-4251 by the Department of Defense’s Medical Supply Chain Pharm FSA. The item is regulated by the FDA and must comply with the DLA Master List of Technical and Quality Requirements, which take precedence over all other packaging standards. Each unit is defined by the unit of issue “BT,” representing 90 capsules per bottle, with all deliveries required to have at least 21 months of remaining shelf life out of a 24-month total shelf life, non-extendable. Packaging must protect against damage and be commercially sealed, with exterior shipping containers suitable for safe transport via common carrier at lowest cost. Palletization must adhere to RP001 DLA Packaging Requirements, and all labeling and marking must follow MIL-STD-129 as the governing standard, superseding references to MIL-STD-129. Markings must include Unit of Issue, Quantity per Unit Pack, freight and mark-for addresses, and traceable identifiers. Parcel post is explicitly prohibited, and shipments must be sent via the fastest traceable means. All items are to be delivered FOB destination within five days of award, with delivery points at Fort Stewart, GA, and Fort Campbell, KY. The contract includes five CLINs totaling 15 BT (1,350 capsules), with no variance allowed in quantity. The drug is supplied by Sandoz Inc., with NDC 00781-2868-92. Technical compliance is enforced through the DLA Master List, which governs all quality and packaging specifications. The product is non-hazardous under FED-STD-313 and must conform to ASTM D3951 for commercial packaging, unless a deviation applies, in which case TQ IP025 governs. All contractors must comply with FAR/DFARS clauses requiring cybersecurity protections under 252.204-7012 and NIST SP 800-171, safeguarding covered defense information and reporting cyber incidents. Contractors must also adhere to whistleblower protections, trafficking in persons prohibitions, employment verification requirements, and sustainable product preferences. Proposal submissions are exclusively through the DLA Internet Bid Board System (DIBBS) by the deadline of July 29, 20

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

IOHEXOL INJECTION

Solicitation # SPE2DP-26-T-4252

IOHEXOL INJECTION, USP, 300MG per mL in 150 mL polymer bottles, packaged in units of 10 bottles per box, is being procured under solicitation SPE2DP-26-T-4252 for delivery to Fort Bragg, North Carolina. The contract specifies a quantity of 24 boxes with a required delivery within five days after the delivery order is issued, and the original required delivery date is July 24, 2026. The item is classified as a Type I (Code Q) medical product with a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20–25°C (68–77°F), with permissible excursions to 15–30°C (59–86°F), protected from strong daylight and direct sunlight, and must not be frozen. Packaging must comply with Commercial standards and the DLA Master List of Technical and Quality Requirements, superseding ASTM D3951 where applicable. All packaging and marking must adhere to Medical Marking Standard No. 1, replacing MIL-STD-129, and include permanent, legible labeling with the correct unit of issue, quantity per unit pack, and barcoding per current specifications. As a hazardous material under OSHA’s Hazard Communication Standard, the product must be accompanied by Safety Data Sheets compliant with 29 CFR 1910.1200 and labeled according to the Globally Harmonized System. Suppliers must submit both SDS and HCS-compliant labels for approval prior to award and must train employees on these requirements. Palletization must meet DLA Packaging Requirements for Procurement (RP001), and shipment must be made by the fastest traceable means, excluding parcel post. The delivery is FOB destination, with inspection and acceptance occurring at the delivery point. The contract incorporates numerous Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including requirements for equal opportunity, combating human trafficking, employment eligibility verification, sustainable products, hazardous material identification, cybersecurity safeguards for covered defense information, whistleblower protections, and prohibitions on certain telecommunications equipment and toxic substances. The contractor must maintain current registration in the System for Award Management and submit invoices exclusively via the Wide Area WorkFlow portal using the appropriate document types. No contract value or unit price is provided in the document, and no evaluation factors, award basis, or past performance criteria are specified. All representations and

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Hazardous Materials Handling and Transportation LogisticsThe contract involves the safe and compliant transportation of hazardous materials under the rigorous standards of DOT HAZMAT regulations under 49 CFR 172, DLA shipping protocols, and applicable commercial container requirements. All work must be performed by certified carriers with the necessary credentials and operational protocols to handle dangerous goods, ensuring zero deviations from federal and departmental safety guidelines. The scope is centered on logistics coordination for the Medical Supply Chain Pharm FSA under the Department of Defense, requiring precise adherence to documentation, labeling, packaging, and transport procedures for hazardous pharmaceutical and medical supplies. Performance is to be conducted with a place of performance listed as FPO 96675, indicating operations may involve overseas or military logistics networks. The solicitation is structured as a subcontract with a response deadline of August 5, 2026, and falls under NAICS code 484220 for hazardous materials transportation. The contract demands full compliance with all regulatory and procedural obligations without exception, and any failure to meet these standards could result in non-performance penalties or contract termination. There is no set-aside designation, meaning all qualified entities may compete, and the focus remains on reliability, regulatory integrity, and timely delivery of critical defense-related hazardous materials.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Military Packaging and Marking ServicesThe contract solicits subcontractor services for the packaging and marking of both hazardous and non-hazardous materials in full compliance with MIL-STD-129, FED-STD-313, and Defense Logistics Agency procurement standards. Work includes precise palletization and export-ready containerization to ensure materials meet military logistics and international shipment requirements. All activities must adhere to strict federal and defense-specific guidelines to maintain readiness and regulatory compliance across the supply chain. The opportunity is posted under NAICS code 322291 and is classified as a subcontract, with a response deadline of August 5, 2026. Performance will be conducted at FPO 96675, with the contracting entity operating under the Department of Defense and specifically managed by the Medical Supply Chain Pharm FSA. The solicitation does not specify a set-aside type and is accessible through the DIBBS platform for qualified subcontractors seeking to support defense logistics operations.

Sanitary Paper Product Manufacturing

POSTED

DEADLINE

Safety Data Sheets (SDS) Management and ComplianceThe contract requires the preparation, maintenance, and timely updating of Safety Data Sheets for all hazardous materials used within the scope of operations, with strict adherence to the Globally Harmonized System of Classification and Labeling of Chemicals, Occupational Safety and Health Administration regulations, and additional contractual obligations. All SDS documentation must be accurate, current, and fully compliant with federal safety standards to ensure the protection of personnel and the environment, as well as to meet the demanding requirements of the Department of Defense’s Medical Supply Chain. Performance is tied to the Federal Supply Activity under the Department of Defense, with work to be performed at FPO, ZIP 96675, and submitted under a subcontract arrangement. The solicitation, identified by the NAICS code 541690 for other scientific and technical consulting services, was posted on July 30, 2026, with responses due by August 5, 2026. Contractors must be prepared to demonstrate full regulatory knowledge and operational capability to manage SDS systems reliably and proactively, ensuring continuous compliance across all hazardous material handling and storage activities.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Hazardous Materials Labeling and Compliance ServicesThis contract requires the application and verification of hazard warning labels that comply with OSHA HazCom standards under 29 CFR 1910.1200 and MIL-STD-129 military marking requirements. The work involves ensuring all hazardous materials are properly labeled to meet federal safety and identification regulations, with emphasis on consistency, accuracy, and compliance across military and industrial supply chains. Performance is expected at an FPO location with ZIP code 96675, indicating operations may involve overseas or maritime logistics environments where standardized labeling is critical for safety and regulatory adherence. The contract is classified as a subcontract under NAICS code 541380, which pertains to other scientific and technical consulting services, and is solicited by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026, indicating a tight turnaround for proposers to demonstrate capability in hazardous materials labeling, quality control, and familiarity with both civilian and military compliance frameworks. Failure to meet labeling standards could result in safety risks or rejection of materiel, making technical expertise and adherence to exact specifications essential for successful contract execution.

Testing Laboratories and Services

POSTED

DEADLINE

Regulatory Compliance and Safety Data ManagementThe contract requires the maintenance and provision of Safety Data Sheets and hazardous material documentation in full alignment with OSHA’s 29 CFR 1910.1200 and NAVSEA 5100-003D standards, ensuring regulatory compliance for all hazardous substances managed under the scope. This includes accurate, up-to-date recordkeeping and timely dissemination of SDS information to meet federal and Department of Defense safety protocols, with particular emphasis on chemical handling, storage, and labeling requirements within military and medical supply operations. The work is to be performed at a designated location in San Diego, CA, with all documentation must adhere to the precise formatting, content, and accessibility mandates specified by the governing regulations. This subcontract falls under NAICS code 541690 and is issued by the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with a response deadline of August 5, 2026. No set-aside designation or specific small business preferences are indicated, and the contract is open to qualified vendors capable of delivering compliant hazardous materials documentation services. All submissions must demonstrate proven experience with DOD regulatory frameworks and the ability to support complex supply chain environments where safety and regulatory adherence are critical to operational continuity and personnel protection.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Domestic Transportation and Final Delivery to Naval VesselThe contract encompasses the domestic transportation and final-mile delivery of medical supplies to the USS Miguel Keith (ESB-5) located in San Diego, California, with the contractor assuming full responsibility for all transportation risks and associated costs from origin to point of delivery on the vessel. The work is classified under NAICS code 484110, indicating it involves truck transportation, and is structured as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA. All logistics must be executed to ensure timely and secure delivery to the specified naval vessel, with performance required at the designated zip code 92136 in San Diego. The solicitation was posted on July 30, 2026, and responses are due by August 5, 2026, leaving a narrow window for interested parties to submit proposals. The contract does not indicate a set-aside classification, meaning it is open to general competition without preference for small businesses or specific socio-economic groups. While details regarding point of contact or specific delivery schedules are not provided, the emphasis on full risk and cost responsibility underscores the need for robust planning, reliable carriers, and compliance with military delivery protocols. The transaction is accessible through the DIBBS system under solicitation number SPE2DP26T4389.

General Freight Trucking, Local

POSTED

DEADLINE

Medical Packaging and Labeling ServicesThe contract calls for specialized packaging, labeling, and barcoding services for pharmaceutical products in strict compliance with MIL-STD-129 and the Medical Marking Standard No. 1, ensuring uniformity and traceability across military supply chains. It requires full adherence to hazardous material handling protocols and robust shelf-life tracking systems to maintain drug efficacy and safety throughout distribution. All work must be performed at the designated place of performance in San Diego, California, with precise attention to regulatory requirements and quality control standards inherent in defense medical logistics. This subcontract opportunity is open for response until August 5, 2026, with posting initiated on July 30, 2026. The North American Industry Classification System code 325991 designates the scope as other pharmaceutical and medicine manufacturing, aligning the effort with specialized medical supply chain operations under the Department of Defense’s Medical Supply Chain Pharm FSA. Bidders must be prepared to meet rigorous defense standards for documentation, marking, and material handling, with no set-aside designation specified, indicating eligibility for all qualified subcontractors.

Custom Compounding of Purchased Resins

POSTED

DEADLINE

Small Business Subcontracting Support (Administrative)The contract seeks administrative support to ensure compliance with subcontracting requirements under DFARS 52.244-6 for commercial subcontracts, focusing on small business outreach and comprehensive recordkeeping. The work involves facilitating the identification, engagement, and documentation of small business subcontractors to meet federal compliance standards, requiring meticulous tracking of subcontracting efforts and accurate maintenance of related records throughout the contract period. The task is administrative in nature and must align with Department of Defense procurement guidelines. The solicitation is open to vendors responding by August 5, 2026, under NAICS code 541611, which pertains to management consulting services. Performance will be conducted at a military postal address in FPO with zip code 09570, indicating overseas or mobile operations support. The contracting activity is managed by the Medical Supply Chain Pharm FSA within the Department of Defense, and while no specific set-aside designation is listed, the emphasis on small business outreach suggests a strong preference for participation by small businesses in the subcontracting process. Proposals must demonstrate capability in navigating federal subcontracting regulations and delivering compliant administrative support under tight timelines.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Cybersecurity Compliance for Covered Defense Information (CDI)This contract requires the implementation of NIST Special Publication 800-171 controls to protect covered defense information as mandated by DFARS 252.204-7012, ensuring that all systems handling such information meet rigorous cybersecurity standards. The subcontractor must establish and maintain appropriate technical, administrative, and physical safeguards to prevent unauthorized access, disclosure, or loss of sensitive data, while also establishing procedures for timely cyber incident reporting in accordance with federal requirements. Compliance is non-negotiable and must be fully operational prior to any handling of covered defense information under this agreement. The work is classified as a subcontract under the NAICS code 541512, associated with the Department of Defense’s Medical Supply Chain Pharm FSA, with performance to occur at the FPO address with ZIP code 09570. Proposals must be submitted by the deadline of August 5, 2026, and the contract is not subject to any specific set-aside provisions. While the point of contact details are not provided, all responses must align with the technical and regulatory expectations outlined in the DFARS clause and NIST framework, with failure to comply potentially resulting in termination or liability. The solicitation is accessible through the specified DIBBS link for further submission details.

Computer Systems Design Services

POSTED

DEADLINE